Olympus Partners has acquired PAI Pharma ("PAI"), the leading developer, manufacturer and distributor of generic oral liquids in both ready-to-dose cups and bottles in the United States. PAI offers ...

Olympus Partners has acquired PAI Pharma, a US-based manufacturer of generic oral liquids. No financial terms were disclosed. Kurt Orlofski serves as CEO of PAI. PAI Pharma has two large manufacturing ...

Modern and rustic styles meet in perfect harmony inside this dwelling, with a nature-inspired color palette, wooden accents, ...